This bill establishes a comprehensive regulatory framework for the production and administration of psilocybin, particularly aimed at assisting individuals suffering from post-traumatic stress disorder (PTSD). It amends Section 124.401 of the Iowa Code to permit individuals to recommend, possess, use, dispense, deliver, transport, or administer psilocybin in accordance with new provisions outlined in Chapter 124F. Key features of the bill include the creation of a Psilocybin Production Establishment Licensing Board within the Department of Health and Human Services, which will oversee licensing, compliance, and operational standards for psilocybin production establishments and qualified therapy providers. The bill also mandates the implementation of an inventory control system for real-time tracking of psilocybin products and establishes strict operational requirements, including limitations on advertising and transportation protocols.

Additionally, the bill introduces new registration requirements for qualified therapy provider agents, who must comply with certification standards, and outlines penalties for non-compliance. It emphasizes the importance of independent testing of psilocybin products and mandates that all products be tested before sale. The legislation also protects qualified providers from civil or criminal penalties for recommending psilocybin and ensures that the use of medical psilocybin does not disqualify individuals from receiving medical care or government employment. Overall, the bill aims to create a structured and accountable system for the safe and regulated use of psilocybin in therapeutic contexts while maintaining public safety and compliance with state laws.

Statutes affected:
Introduced: 124.401